Werewolf Therapeutics Inc - fluxo de caixa (NASDAQ:HOWL) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -42.88 M-40.6 M-32.61 M-56.19 M-60.29 M -60.29 M Cash from investing activities -498 K-3.61 M-769 K-254 K0 0 Cash from financing activities 109.43 M15.91 M58.43 M13.08 M6.03 M 6.03 M Free cash flow -43.37 M-44.21 M-33.38 M-56.44 M-60.29 M -60.29 M

Notícias

Truist sees positive reaction for biotech stocks after FDA official exit

Werewolf Therapeutics explora venda e alternativas estratégicas

Werewolf Therapeutics explores sale and strategic alternatives

Ações da Werewolf Therapeutics caem após anúncio de redução de 64% da força de trabalho

Werewolf Therapeutics stock falls after announcing 64% workforce reduction

Werewolf Therapeutics recebe notificação da Nasdaq por deficiência no preço mínimo de oferta

Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency

Diretor da Werewolf Therapeutics, Luke Evnin, vende ações no valor de US$ 20.942

Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock

Evnin Luke vende ações da Werewolf Therapeutics (HOWL) por US$ 53.533

Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533

Diretor Luke Evnin vende ações da Werewolf Therapeutics (HOWL) por US$ 45.882